PSOP12 (PF3D7_0513700) is a secreted sexual-stage antigen required for Plasmodium transmission through the mosquito (PMID:18761621). In P. berghei, its ortholog is expressed on the surface of male and female gametes and ookinetes, and disruption of the gene causes a significant reduction in mosquito-stage parasite numbers that blocks transmission (PMID:18761621, PMID:25454088). Its expression during ookinete development is under transcriptional control of the AP2-O transcription factor, which binds the upstream genomic region of PSOP12 in P. berghei ookinetes (PMID:26018192). In non-activated P. berghei gametocytes the protein localizes adjacent to the parasitophorous vacuole and red blood cell membranes, and upon gametocyte activation it is secreted and becomes trapped between the ruptured PVM and RBC membrane, defining PSOP12 as a protein released during egress/activation (PMID:29476099). Antibodies raised against recombinant P. berghei PSOP12 recognize the gamete and ookinete surface and confer transmission-blocking activity both in vivo and ex vivo, establishing it as a functional transmission-blocking vaccine candidate (PMID:25454088). Beyond expression, localization, secretion, and its knockout transmission phenotype, no molecular interaction partners, biochemical activity, or structural detail for PSOP12 have been characterized in the available corpus.